Article Versions Notes

Struckmeier A-K, Radermacher A, Fehrenz M, Alansary D, Wartenberg P, Wagner M, Scheller A, Hess J, Moratin J, Freudlsperger C, et al. TREM2 Is Associated with Advanced Stages and Inferior Prognosis in Oral Squamous Cell Carcinoma. Cancers. 2022; 14(19):4635. https://doi.org/10.3390/cancers14194635

Struckmeier, Ann-Kristin, Anne Radermacher, Michael Fehrenz, Dalia Alansary, Philipp Wartenberg, Mathias Wagner, Anja Scheller, Jochen Hess, Julius Moratin, Christian Freudlsperger, and et al. 2022. "TREM2 Is Associated with Advanced Stages and Inferior Prognosis in Oral Squamous Cell Carcinoma" Cancers 14, no. 19: 4635. https://doi.org/10.3390/cancers14194635

Struckmeier, A.-K., Radermacher, A., Fehrenz, M., Alansary, D., Wartenberg, P., Wagner, M., Scheller, A., Hess, J., Moratin, J., Freudlsperger, C., Hoffmann, J., Thurner, L., Roemer, K., Freier, K., & Horn, D. (2022). TREM2 Is Associated with Advanced Stages and Inferior Prognosis in Oral Squamous Cell Carcinoma. Cancers, 14(19), 4635. https://doi.org/10.3390/cancers14194635